MKI67 and breast cancer: The primary goal of this study was breast tumor‐profiling (ER, PR, HER2, Ki‐67) to determine the distribution of molecular subtypes, and clinicopathology characterization across a large cross section of patients with breast cancer attending a cancer center in Iraq.